CMS 2027 Home Health Rule: Owner Violations Can Cost Medicare Enrollment, and PE Buyers Must Re-Enroll
CMS’s 2027 Home Health Prospective Payment System final rule lets the agency deny or revoke Medicare enrollment over violations by a provider’s owners or parent companies, not only the provider’s own. Triggers named include a license suspended or revoked in another state and suspension from another federal health care program. Home health agencies, hospices and medical equipment suppliers must re-enroll as new providers after a change in majority ownership, such as a private equity acquisition; failing new accreditation could cost them the ability to bill or enroll. Regulators say the owner-conduct changes would save taxpayers $82 million annually. The same rule gives home health agencies $415 million more next year, a 2.4% increase.
Owner-level enforcement and mandatory re-enrollment change diligence and timing for any buyer of a hospice, home health or DME platform. Closing a deal no longer guarantees uninterrupted Medicare billing.
Use it for: Home health, hospice or DME deal teams and the platforms they back, when screening targets and sequencing a close.
Watch out for: The brief names no effective date, re-enrollment deadline or ownership-percentage threshold beyond “majority,” and does not say which provider types the expanded denial authority covers. Read the Federal Register text before building it into a model.
Try this: Add two diligence checks: list every owner and parent-company license or program sanction, and map the re-enrollment and accreditation timeline against the expected close, then stress-test the cash gap in the valuation calculator.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.